We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more OK
Roche Menu Search Global Web Site : Media

You are here:

Roche Language: DE
  • Home
  • About Roche
  • Products
  • Sustainability
  • Research & Development
  • Partnering
  • Media
  • Investors
  • Careers
media-1920

Media

Choose your required content type and access a wide range of materials relating to our company, people, medicines and diagnostic tools.

Media Releases

All
Published on: 17 January 2019

FDA accepts Roche’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer

 more
Published on: 17 December 2018

PRIME designation granted by European Medicines Agency for Roche’s risdiplam for treatment of spinal muscular atrophy (SMA)

 more
image

Events

Learn more about upcoming media events.

 more
image

Subscribe to Roche Media Releases

Get the latest news and updates to your inbox.

 more
image

Media contacts

Contact details for media inquiries.

 more
image

Company information

Gain insights into our company.

 more
image

Media library

Image and footage related to our people. medicines and diagnostics tools.

 more
Share
  • Share via email
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google+
  • Share on Xing
Close
  • © 2019 F. Hoffmann-La Roche Ltd
  • 19.01.2019
  • Legal Statement
  • Privacy Policy

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

  • Twitter
  • LinkedIn
  • Facebook
  • YouTube